28 Feb, 2024 08:19 AM
-- Revenue of US$22.2m, up 89% year-on-year (yoy) with 2H FY23 revenue of US$12.1m in line with 2H FY23 guidance of US$12m-14m provided in October 2023
-- Product Sales of US$22.1m, up 90% yoy refl...read more
30 Jan, 2024 08:20 AM
-- FY23 Revenue of US$22.2m, up 89.4% on pcp2 with 2H FY23 revenue of US$12.1m in line with 2H FY23 guidance of US$12m-14m provided in October 2023.
-- 4Q FY23 Product Sales of US$7.1m, up 123.5% o...read more
22 Sep, 2023 12:16 PM
Sydney, Australia Friday, 22 September 2023, Next Science Limited (ASX:NXS) (Next Science or the Company), a medical technology company focused on commercialising its proprietary XBIO™ suite o...read more
29 Aug, 2023 09:47 AM
The securities of Next Science Limited (‘NXS’) will be placed in trading halt at the request of NXS, pending it releasing an announcement. Unless ASX decides otherwise, the securities wi...read more